KRYSTEXXA® (pegloticase) | Uncontrolled Gout Treatment
Release your everyday from gout with KRYSTEXXA, a treatment that lowers uric acid and can dissolve years of gout buildup in months, according to studies. Call a Gout Nurse Advocate for help at 1-833-469-4688
FDA Approves Canakinumab to Treat Gout Flares
2023年11月3日 · On Aug. 25, the U.S. Food & Drug Administration (FDA) approved canakinumab (Ilaris) for the treatment of gout flares in adult patients who can’t tolerate non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine, or for whom NSAIDs and colchicine are contraindicated or provide an inadequate response.
FDA approves Ilaris for the treatment of gout flares in adults
2023年8月31日 · The FDA has approved Ilaris for the treatment of gout flares in adults, marking it as the first biologic therapy to receive the nod for this indication, according to a statement from Novartis...
FDA Roundup: Pipeline Drugs for Gout - Rheumatology Advisor
2024年2月9日 · These emerging interventions not only target the acute symptoms of gout but also aim to address the underlying cause — hyperuricemia — with the goal of achieving lasting reductions in serum urate levels. 1 From advanced xanthine oxidase inhibitors to groundbreaking strategies in specific NOD-like receptor family, pyrin domain-containing 3 protei...
New Gout Drugs Might Increase Patients at Target Urate Level - Medscape
2024年7月9日 · Now at 12 months, the benefits have proven to be generally sustained with no new safety signals, according to Herbert S.B. Baraf, MD, The Center for Rheumatology and Bone Research, Wheaton,...
A Different Kind of Uric Acid Treatment - KRYSTEXXA
KRYSTEXXA is the only FDA-approved treatment for out-of-control gout, and it’s approved to be given with methotrexate. Methotrexate helps KRYSTEXXA work better than it did before. Your doctor may prescribe KRYSTEXXA with methotrexate to reduce symptoms caused by …
Emerging therapeutic options for refractory gout - Nature
2023年12月15日 · For individuals with gout, the treatment options beyond conventional urate-lowering therapies are expanding. Notable advancements in 2023 include developments in uricase therapy, new xanthine...
FDA Approves Canakinumab for Gout Flares - Medscape
2023年8月30日 · The US Food and Drug Administration (FDA) has approved canakinumab (Ilaris) for the treatment of gout flares in adults who cannot be treated with NSAIDs, colchicine, or...
5 Medically-Approved Gout Treatments - Harvard Health
2023年5月31日 · The ACR guidelines recommend treating gout with uric acid-lowering medications for people who have tophi (nodules that form from a mass of uric acid crystals at joints or in soft tissues), radiographic evidence (X-ray or other imaging) of damage due to gout, kidney stones (people with gout have an increased risk of kidney stones as uric acid ...
Novel Gout Drug Passes Mid-Stage Test - Medpage Today
2023年1月20日 · An investigational non-purine xanthine oxidase inhibitor for gout treatment, called tigulixostat, appeared effective enough in a phase II trial that a pivotal study is now getting underway.